{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:46:57Z","timestamp":1784288817333,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118596","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:28:10Z","timestamp":1768955290000},"page":"118596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The mitochondrial gambit: Re-evaluating Antimycin A as a multi-pronged anti-cancer agent"],"prefix":"10.1016","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4341-5188","authenticated-orcid":false,"given":"Woo Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115540","article-title":"Unraveling the nexus: genomic instability and metabolism in cancer","volume":"44","author":"Gujar","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-024-02069-w","article-title":"Cancer, metastasis, and the epigenome","volume":"23","author":"Kiri","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib3","article-title":"Precision oncology: using cancer genomics for targeted therapy advancements","volume":"1880","author":"Avci","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118596_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41568-024-00754-y","article-title":"Emerging strategies to investigate the biology of early cancer","volume":"24","author":"Zhou","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118596_bib5","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1016\/S2589-7500(24)00150-X","article-title":"Deep learning assessment of senescence-associated nuclear morphologies in mammary tissue from healthy female donors to predict future risk of breast cancer: a retrospective cohort study","volume":"6","author":"Heckenbach","year":"2024","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.ejmech.2026.118596_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111744","article-title":"Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas","volume":"140","author":"Herrero","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2026.118596_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10863-025-10059-w","article-title":"The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer","volume":"57","author":"Seyfried","year":"2025","journal-title":"J. Bioenerg. Biomembr."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118596_bib8","article-title":"The mitochondrial nexus: targeting metabolic vulnerabilities, oxidative stress, and immunomodulation to induce cancer cell death","volume":"1880","author":"Park","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118596_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104189","article-title":"MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer","volume":"29","author":"Pulous","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118596_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2025.02.004","article-title":"Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy","volume":"110","author":"Yang","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"8075","key":"10.1016\/j.ejmech.2026.118596_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","article-title":"Nerve-to-cancer transfer of mitochondria during cancer metastasis","volume":"644","author":"Hoover","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118596_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67624","article-title":"Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells","volume":"10","author":"Le Vasseur","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12935-022-02788-4","article-title":"Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cells","volume":"22","author":"Matassa","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.118596_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108506","article-title":"The mitochondrial nexus: dysfunction, inhibition, and therapeutic frontiers in lung disease","volume":"250","author":"Park","year":"2025","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118596_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167549","article-title":"Cancer stem cells: masters of all traits","volume":"1871","author":"Leck","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2026.118596_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178382","article-title":"Targeting the powerhouse: a critical review of mitochondrial inhibitors as a therapeutic strategy in lung cancer","author":"Park","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2015.06.007","article-title":"FOXM1-Induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function","volume":"149","author":"Song","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13287-023-03563-6","article-title":"Mesenchymal stromal cells secretome restores bioenergetic and redox homeostasis in human proximal tubule cells after ischemic injury","volume":"14","author":"Faria","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118596_bib19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11427-024-2831-x","article-title":"Gut microbiota in cancer initiation, development and therapy","volume":"68","author":"Zhang","year":"2025","journal-title":"Sci. China Life Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118596_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70176","article-title":"Tissue-specific effects of dietary protein on cellular senescence are mediated by branched-chain amino acids","volume":"24","author":"Calubag","year":"2025","journal-title":"Aging Cell"},{"issue":"24","key":"10.1016\/j.ejmech.2026.118596_bib21","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3390\/cancers14246214","article-title":"Metabolomic and mitochondrial fingerprinting of the epithelial-to-mesenchymal transition (EMT) in non-tumorigenic and tumorigenic human breast cells","volume":"14","author":"Cuy\u00e0s","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00018-024-05361-6","article-title":"Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress","volume":"81","author":"Jacquemin","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118596_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35055095","article-title":"Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3","volume":"3","author":"Tzung","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41420-024-01947-y","article-title":"Nano-flow cytometry unveils mitochondrial permeability transition process and multi-pathway cell death induction for cancer therapy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov."},{"issue":"31","key":"10.1016\/j.ejmech.2026.118596_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2511890122","article-title":"In situ cryo-ET visualization of mitochondrial depolarization and mitophagic engulfment","volume":"122","author":"Rose","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.ejmech.2026.118596_bib26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2174\/0929867033457241","article-title":"Bcl-2-related proteins as drug targets","volume":"10","author":"O'Neill","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118596_bib27","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1158\/1535-7163.MCT-06-0767","article-title":"2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition","volume":"6","author":"Schwartz","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.118596_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106697","article-title":"Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis","volume":"189","author":"Shi","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.118596_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-009-0222-2","article-title":"The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione","volume":"333","author":"Han","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20081258","article-title":"Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation","volume":"418","author":"Aykin-Burns","year":"2009","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118596_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molcel.2020.12.034","article-title":"Mitochondrial NAD+ controls nuclear ARTD1-induced ADP-ribosylation","volume":"81","author":"Hopp","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.118596_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103871","article-title":"Noninvasive in vivo discrimination between mitochondrial ROS and global ROS production in solid tumors using EPR spectroscopy","volume":"87","author":"Mathieu","year":"2025","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1099\/mic.0.000572","article-title":"A phylogenetic and evolutionary analysis of antimycin biosynthesis","volume":"164","author":"Joynt","year":"2018","journal-title":"Microbiology"},{"key":"10.1016\/j.ejmech.2026.118596_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111805","article-title":"Antimycin A: from mitochondrial poison to multifaceted biological probe and therapeutic agent","volume":"422","author":"Park","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118596_bib35","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1074\/jbc.M708608200","article-title":"Inhibitor-complexed structures of the cytochrome bc1 from the photosynthetic bacterium Rhodobacter sphaeroides","volume":"283","author":"Esser","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022120118","article-title":"Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction","volume":"118","author":"Condon","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2026.118596_bib37","article-title":"Mitochondria-mediated retrograde responses evoked by inhibitor antimycin A and mtDNA elimination in Chlamydomonas reinhardtii","volume":"318","author":"Khan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.118596_bib38","article-title":"Aptly chosen, effectively emphasizing the action and mechanism of antimycin A(1)","volume":"15","author":"Zhu","year":"2024","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118596_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.lungcan.2008.11.005","article-title":"Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis","volume":"65","author":"Han","year":"2009","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12032-022-01901-x","article-title":"Antimycin A induced apoptosis in HCT-116 colorectal cancer cells through the up- and downregulation of multiple signaling pathways","volume":"40","author":"Kabir","year":"2022","journal-title":"Med. Oncol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118596_bib41","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/tox.22986","article-title":"Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress-mediated apoptosis and DNA damage","volume":"35","author":"Yu","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"20","key":"10.1016\/j.ejmech.2026.118596_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jnci\/djj395","article-title":"Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak","volume":"98","author":"Tomiyama","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118596_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105083","article-title":"Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening","volume":"299","author":"Liu","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118596_bib67","first-page":"689","article-title":"Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells","volume":"20","author":"Han","year":"2008","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib68","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/ijo.2012.1575","article-title":"Antimycin A sensitizes cells to TRAIL-induced apoptosis through upregulation of DR5 and downregulation of c-FLIP and Bcl-2","volume":"41","author":"Lee","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2026.118596_bib69","article-title":"Marine Streptomyces sp. derived antimycin analogues suppress HeLa cells via depletion HPV E6\/E7 mediated by ROS-dependent ubiquitin-proteasome system","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib70","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.27976","article-title":"Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression","volume":"62","author":"Lee","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.118596_bib71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2021.02.027","article-title":"Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia","volume":"547","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118596_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111058","article-title":"Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells","volume":"133","author":"Datta","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.118596_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/910451","article-title":"A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent","volume":"2013","author":"Yeh","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejmech.2026.118596_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118596_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15548627.2019.1628520","article-title":"PHB2 (prohibitin 2) promotes PINK1-PRKN\/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis","volume":"16","author":"Yan","year":"2020","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118596_bib49","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1080\/15548627.2023.2230839","article-title":"Deciphering the mitophagy receptor network identifies a crucial role for OPTN (optineurin) in acute myeloid leukemia","volume":"19","author":"Meyer","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15548627.2024.2392408","article-title":"Mitochondrial bioenergetics stimulates autophagy for pathological MAPT\/Tau clearance in tauopathy neurons","volume":"21","author":"Jia","year":"2025","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118596_bib51","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1080\/15548627.2024.2341588","article-title":"The Wolfram-like variant WFS1E864K destabilizes MAM and compromises autophagy and mitophagy in human and mice","volume":"20","author":"Patergnani","year":"2024","journal-title":"Autophagy"},{"issue":"17","key":"10.1016\/j.ejmech.2026.118596_bib52","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/cells13171433","article-title":"Metformin alleviates inflammation and induces mitophagy in human retinal pigment epithelium cells suffering from mitochondrial damage","volume":"13","author":"Toppila","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118596_bib53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15548627.2024.2437908","article-title":"Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial function","volume":"21","author":"Chung","year":"2025","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118596_bib54","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1074\/jbc.M306021200","article-title":"Bcl-XL mutations suppress cellular sensitivity to antimycin A","volume":"279","author":"Manion","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118596_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00280-004-0978-8","article-title":"Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents","volume":"56","author":"Wang","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118596_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105326","article-title":"Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3","volume":"164","author":"Bachmann","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118596_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05741","article-title":"The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells","volume":"6","author":"Petricciuolo","year":"2020","journal-title":"Heliyon"},{"issue":"17\u201318","key":"10.1016\/j.ejmech.2026.118596_bib58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","article-title":"The significance of mitochondrial toxicity testing in drug development","volume":"12","author":"Dykens","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118596_bib59","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"22","key":"10.1016\/j.ejmech.2026.118596_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182087","article-title":"Disruption of mitochondrial electron transport impairs urinary concentration via AMPK-dependent suppression of aquaporin 2","volume":"9","author":"Carty","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2026.118596_bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.freeradbiomed.2024.01.034","article-title":"Cardiomyocyte maturation alters molecular stress response capacities and determines cell survival upon mitochondrial dysfunction","volume":"213","author":"Schraps","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118596_bib62","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/ijms26062435","article-title":"\"Villains\" turning good: Antimycin A and rotenone, mitochondrial respiratory chain inhibitors, protect H9c2 cardiac cells against insults triggering the intrinsic apoptotic pathway","volume":"26","author":"Zikaki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118596_bib72","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/acssynbio.4c00193","article-title":"Engineered biosynthesis and anticancer studies of ring-expanded antimycin-type depsipeptides","volume":"13","author":"Hu","year":"2024","journal-title":"ACS Synth. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118596_bib63","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118596_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12967-025-06435-0","article-title":"Nanocarriers for cutting-edge cancer immunotherapies","volume":"23","author":"Hu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.ejmech.2026.118596_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400261","article-title":"Advances in polymeric nanomaterial-mediated autophagy for cancer therapy","volume":"25","author":"Zhao","year":"2024","journal-title":"Chembiochem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:33:00Z","timestamp":1771911180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"alternative-id":["S0223523426000413"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118596","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mitochondrial gambit: Re-evaluating Antimycin A as a multi-pronged anti-cancer agent","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118596"}}